BioHarvest Sciences Inc. Common Stock

BHST · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$12,913-$12,564-$11,236-$9,827
Dep. & Amort.$1,251$840$712$386
Deferred Tax$0$0$0$0
Stock-Based Comp.$601$563$0$3,367
Change in WC-$555$755-$308-$96
Other Non-Cash$4,932$1,884$1,591-$627
Operating Cash Flow-$6,684-$8,522-$9,241-$6,794
Investing Activities
PP&E Inv.-$2,835-$1,474-$1,256-$1,640
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$192$0$0$0
Investing Cash Flow-$3,027-$1,474-$1,256-$1,640
Financing Activities
Debt Repay.$2,042$13,153$7,658-$332
Stock Issued$4,330$534$877$7,466
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$408-$131-$397$3,638
Financing Cash Flow$6,780$13,556$8,138$10,772
Forex Effect-$34$59-$22-$4
Net Chg. in Cash-$2,965$3,619-$2,381$2,334
Supplemental Information
Beg. Cash$5,355$1,736$4,117$1,783
End Cash$2,390$5,355$1,736$4,117
Free Cash Flow-$9,519-$9,996-$10,497-$8,434